FR2088218A1 - Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states - Google Patents

Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states

Info

Publication number
FR2088218A1
FR2088218A1 FR7019650A FR7019650A FR2088218A1 FR 2088218 A1 FR2088218 A1 FR 2088218A1 FR 7019650 A FR7019650 A FR 7019650A FR 7019650 A FR7019650 A FR 7019650A FR 2088218 A1 FR2088218 A1 FR 2088218A1
Authority
FR
France
Prior art keywords
treatment
nephropathic
compsns
lactulose
acidosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7019650A
Other languages
French (fr)
Other versions
FR2088218B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7019650A priority Critical patent/FR2088218A1/en
Publication of FR2088218A1 publication Critical patent/FR2088218A1/en
Application granted granted Critical
Publication of FR2088218B1 publication Critical patent/FR2088218B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compsns. contg. lactulose (I) and Cytochrome C (II) or hematoporphyrin are active in the treatment of nephropathic acidosis auto-toxic conditions such as diabetes. They also aid medicaments having a vitamin P activity in the treatment of atherosclerosis. The dosage is 0.050-0.070 g (I), 1-12 times daily, administered orally or parenterally. Typically, tablets were prepd. contg. 0.070 g (I), 2 mg (II), and 0.10 g. alpha-chymotripsin, together with conventional excipients.
FR7019650A 1970-05-29 1970-05-29 Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states Granted FR2088218A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7019650A FR2088218A1 (en) 1970-05-29 1970-05-29 Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7019650A FR2088218A1 (en) 1970-05-29 1970-05-29 Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states

Publications (2)

Publication Number Publication Date
FR2088218A1 true FR2088218A1 (en) 1972-01-07
FR2088218B1 FR2088218B1 (en) 1973-08-10

Family

ID=9056325

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7019650A Granted FR2088218A1 (en) 1970-05-29 1970-05-29 Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states

Country Status (1)

Country Link
FR (1) FR2088218A1 (en)

Also Published As

Publication number Publication date
FR2088218B1 (en) 1973-08-10

Similar Documents

Publication Publication Date Title
ES352030A1 (en) Urate oxidase and process for the production thereof
GB1380171A (en) Medicinal tablets
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
FR2088218A1 (en) Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states
DE3883208D1 (en) AGENTS FOR TREATING KERATOSIS.
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
GB950162A (en) Medicines for the treatment of hepatic disorders
Viukari et al. Effect of methyldopa on tardive dyskinesia in psychogeriatric patients.
GB911482A (en) Pharmaceutical tablets comprising a synergistic combination including salts of ยช--phenoxyethyl penicillin
GB1437138A (en) Method of increasing sexual potency
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB976096A (en) Pharmaceutical compositions
Misra A comparative study of tinidazole and metronidazole as a single daily dose for three days in symptomatic intestinal amoebiasis
GB1375806A (en)
SU1273109A1 (en) Method of treatment of exema and exematized mycosis of foot
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
IE36780B1 (en) New pharmaceutical preparations
FR2154506A1 (en) Medicaments contg biotin - as hypoglycaemic agents
SU315388A1 (en) Medicine
FR2092649A1 (en) Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
FR2152408A1 (en) Haemorrhoids treatment - using pomegranate peel suspension
GB1379959A (en) Pyrrolidino hydroxy-pentanes
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
GB1305179A (en)

Legal Events

Date Code Title Description
ST Notification of lapse